See also this year's filing and all EDGAR filings for this company.
PDF Report 0001302573_2016_Oncomed_Pharmaceuticals_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001302573, Oncomed Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 231,255,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 4,825,000 |
| 3 | remainder_Assets | 1,807,000 |
| 4 | LiabilitiesCurrent | 52,641,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 181,695,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 18,583,000 |
| 9 | ResearchAndDevelopmentExpense | 92,873,000 |
| 10 | remainder_Expenses | 20,000 |
| 11 | remainder_Revenues | 25,899,000 |
| 12 | remainder_NetIncome | 170,000 |
| 13 | remainder_ComprehensiveNetIncome | 37,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 237,887,000 |
| 1 | Liabilities | 234,336,000 |
| 2 | Expenses | 111,476,000 |
| 3 | Revenues | 25,899,000 |
| 4 | StockholdersEquity | 3,551,000 |
| 5 | NetIncome | -85,407,000 |
| 6 | ComprehensiveNetIncome | -85,388,500 |
| 7 | BaseVar | 304,902,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.329 |
| 9 | EconomicCapitalRatio | 1.40 |
Edgar->Model Mapping
Feature Distribution
Change over Time
